Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

TSX:TRIL - Post Discussion

Trillium Therapeutics Inc. > it's a sell today for me
View:
Post by coolfooldumbguy on Jan 24, 2020 10:34am

it's a sell today for me

at $4.61 cents U.S. per share, got this one at the beginning of the month and it's done really well, and don't want to be too greedy,so glta shareholders.
Comment by PLD1 on Jan 24, 2020 12:07pm
Looks like it's worked out for you so far. I have never had much success with stock timing. I believe in the science behind this company as do many others, and believe that it will climb much much higher. I did anticipate a bit of a pullback after such a large surge the last little while but will stay in the stock, ride the waves and wait for the real gains to come after the next set of trials ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities